We are no longer accepting new cases.
Trustwell Law is accepting cases on behalf of patients with arthritis or ulcerative colitis who have taken Xeljanz or Xeljanz XR and developed a pulmonary embolism (PE) or deep vein thrombosis (DVT).
Have you, a family member, or someone you know taken Xeljanz or Xeljanz XR (tofacitinib) for rheumatoid arthritis, psoriatic arthritis, or ulcerative colitis and developed a pulmonary embolism (PE) or deep vein thrombosis (DVT) or died due to a PE or DVT during treatment or within 3 days of the last dose? If so, you should contact us.
The FDA originally approved Xeljanz and Xeljanz XR to treat certain adults with moderate or severe rheumatoid arthritis (RA) who did not respond well to methotrexate. The FDA has also approved the drug for adults with psoriatic arthritis or ulcerative colitis.
A recent clinical trial found that patients taking 10 mg of Xeljanz twice a day for rheumatoid arthritis showed increased risks of pulmonary embolism and higher death rates than patients in the control group. The FDA had not approved the 10-mg twice-a-day dose for rheumatoid arthritis; that dose had only been approved for ulcerative colitis.
The trial for rheumatoid arthritis was allowed to continue after this discovery, but only at the lower, 5-mg twice-a-day dose.
Pulmonary embolisms and deep vein thrombosis are sometimes referred to collectively as venous thromboembolism or venous thromboembolic events (VTE). The packaging for Xeljanz and Xeljanz XR does not contain a warning about the risk of VTE.
The FDA has now warned doctors and patients about the risk of taking the 10-mg twice-a-day dose of Xeljanz and Xeljanz XR for rheumatoid arthritis.
The FDA further warns patients taking Xeljanz and Xeljanz XR that they should not alter their dose or stop taking the medication without consulting their physicians.
If you or a loved one experienced a pulmonary embolism or deep vein thrombosis or died while taking any level dose of Xeljanz or Xeljanz XR for rheumatoid arthritis, psoriatic arthritis, or ulcerative colitis, or within three days of the last dose, contact us. Our lawyers would be honored to help you.
We have access to the expertise, resources, and manpower to fully investigate each case and fight for and with our clients against the big corporations to seek the justice they deserve. You pay nothing unless we win your case.